Fig. 8From: SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent mannerSchematic diagram of how SPTBN1 abrogates ccRCC progression through reprogramming glycolysis in a GPT2-dependent manner. Our research highlighted the mechanism of the SPTBN1-GPT2 axis in regulating glycolysis to abrogate ccRCC progression. These molecules and pathway may represent therapeutic targets to treat ccRCCBack to article page